Quantification of EGFP Expression in Living Cells of the Mouse Retina and Parallel Electrophysiological Assessment of Cell Health
Tonia S. Rex(Vanderbilt University Medical Center), Jean Bennett(Penn Presbyterian Medical Center), Arkady Lyubarsky(Penn Presbyterian Medical Center), E. M. Surace, Edward N. Pugh(Membrane Technology & Research (United States)), Thomas E. Hughes(Montana State University), Peter D. Calvert(Duke University), J. Peet(University of Pennsylvania), Sergei Nikonov(Penn Presbyterian Medical Center)
Investigative Ophthalmology & Visual Science
May 1, 2005
Cited by 0
Related Papers
Safety and Efficacy of Gene Transfer for Leber's Congenital Amaurosis
|New England Journal of Medicine|2008|2.1k
Age-dependent effects of RPE65 gene therapy for Leber's congenital amaurosis: a phase 1 dose-escalation trial
|The Lancet|2009|864
Gene Therapy for Leber's Congenital Amaurosis is Safe and Effective Through 1.5 Years After Vector Administration
|Molecular Therapy|2009|551
Mutation of a nuclear receptor gene, NR2E3, causes enhanced S cone syndrome, a disorder of retinal cell fate
|Nature Genetics|2000|506
AAV2 Gene Therapy Readministration in Three Adults with Congenital Blindness
|Science Translational Medicine|2012|394